GSK swine flu drug approved in US: company

November 11, 2009

British drug maker GlaxoSmithKline has announced that US regulators have approved its swine flu vaccine for adults in the United States.

"The US Food and Drug Administration (FDA) has approved a... license application for its unadjuvanted influenza A (H1N1) pandemic vaccine," GSK said in a statement received on Wednesday.

"The United States Department of Health and Human Services has placed an order to fill 7.6 million doses of unadjuvanted H1N1 pandemic vaccine from GSK, which will contribute to the approximately 250 million doses secured by the US government."

Although the is used to fight swine flu, its make-up is different to Pandemrix -- GSK's drug recently approved by EU regulators to treat in Europe.

(c) 2009 AFP

Related Stories

Recommended for you

Universal flu vaccine designed by scientists

September 30, 2016

An international team of scientists have designed a new generation of universal flu vaccines to protect against future global pandemics that could kill millions.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.